• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

液晶基质的纳米结构决定了亲水性模型药物的体外缓释和体内口服吸收动力学。

Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs.

作者信息

Lee Kathy W Y, Nguyen Tri-Hung, Hanley Tracey, Boyd Ben J

机构信息

Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), 381 Royal Parade, Parkville, Victoria 3052, Australia.

出版信息

Int J Pharm. 2009 Jan 5;365(1-2):190-9. doi: 10.1016/j.ijpharm.2008.08.022. Epub 2008 Aug 26.

DOI:10.1016/j.ijpharm.2008.08.022
PMID:18790030
Abstract

Nanostructured lipid-based liquid crystalline systems have been proposed as sustained oral drug delivery systems, but the interplay between their intrinsic release rates, susceptibility to digestive processes, and the manner in which these effects impact on their application in vivo, are not well understood. In this study, two different bicontinuous cubic phases, prepared from glyceryl monooleate and phytantriol, and a reversed hexagonal phase formed by addition of a small amount of vitamin E to phytantriol (Q(II GMO), Q(II PHYT) and H(II PHYT+VitEA), respectively) were prepared. The release kinetics for a number of model hydrophilic drugs with increasing molecular weights (glucose, Allura Red and FITC-dextrans) was determined in in vitro release experiments. Diffusion-controlled release was observed in all cases as anticipated from previous studies with liquid crystalline systems, and it was discovered that the release rates of each drug decreased as the matrix was changed from Q(II GMO) to Q(II PHYT) to H(II PHYT+VitEA). Formulations containing (14)C-glucose, utilized as a rapidly absorbed marker of drug release, were then orally administered to rats to determine the relative in vivo absorption rates from the different formulations. The results showed a trend by which the rate of absorption of (14)C-glucose followed that observed in the corresponding in vitro release studies, providing the first indication that the nanostructure of these materials may provide the ability to tailor the absorption kinetics of hydrophilic drugs in vivo, and hence form the basis of a new drug delivery system.

摘要

基于纳米结构脂质的液晶体系已被提议作为口服缓释给药系统,但对于其固有释放速率、对消化过程的敏感性以及这些效应在体内应用中的影响方式之间的相互作用,人们尚未完全理解。在本研究中,制备了由单油酸甘油酯和植烷三醇形成的两种不同的双连续立方相,以及通过向植烷三醇中添加少量维生素E形成的反相六方相(分别为Q(II GMO)、Q(II PHYT)和H(II PHYT+VitEA))。在体外释放实验中测定了多种分子量递增的模型亲水性药物(葡萄糖、诱惑红和异硫氰酸荧光素标记的葡聚糖)的释放动力学。正如先前对液晶体系的研究所预期的那样,在所有情况下均观察到扩散控制释放,并且发现随着基质从Q(II GMO)变为Q(II PHYT)再变为H(II PHYT+VitEA),每种药物的释放速率均降低。然后将含有作为药物释放快速吸收标记物的(14)C-葡萄糖的制剂口服给予大鼠,以确定不同制剂的相对体内吸收速率。结果显示出一种趋势,即(14)C-葡萄糖的吸收速率遵循在相应体外释放研究中观察到的趋势,这首次表明这些材料的纳米结构可能具有在体内调节亲水性药物吸收动力学的能力,从而构成一种新型药物递送系统的基础。

相似文献

1
Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs.液晶基质的纳米结构决定了亲水性模型药物的体外缓释和体内口服吸收动力学。
Int J Pharm. 2009 Jan 5;365(1-2):190-9. doi: 10.1016/j.ijpharm.2008.08.022. Epub 2008 Aug 26.
2
Stimuli responsive liquid crystals provide 'on-demand' drug delivery in vitro and in vivo.刺激响应性液晶在体外和体内实现“按需”药物递送。
J Control Release. 2009 May 5;135(3):218-26. doi: 10.1016/j.jconrel.2009.01.009. Epub 2009 Jan 23.
3
Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation.植物三醇和甘油单油酸酯立方液晶相作为难溶性药物的口服控释给药系统 II. 体内评价。
J Pharm Pharmacol. 2010 Jul;62(7):856-65. doi: 10.1211/jpp.62.06.0006.
4
Evaluating the link between self-assembled mesophase structure and drug release.评估自组装介相结构与药物释放的关系。
Int J Pharm. 2011 Dec 12;421(1):176-82. doi: 10.1016/j.ijpharm.2011.09.022. Epub 2011 Sep 22.
5
Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin E acetate and F127 polymer on liquid crystal nanostructure.植烷三醇的本体和分散水相行为:维生素E醋酸酯和F127聚合物对液晶纳米结构的影响。
Langmuir. 2006 Nov 7;22(23):9512-8. doi: 10.1021/la061706v.
6
Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water soluble drugs I. Phase behaviour in physiologically-relevant media.植物三醇和甘油单油酸酯立方液晶相作为难溶性药物的口服控释给药系统 I. 在生理相关介质中的相行为。
J Pharm Pharmacol. 2010 Jul;62(7):844-55. doi: 10.1211/jpp.62.06.0005.
7
Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: Characterisation, swelling and release kinetics.含亲水性蛋白质的植物三醇和甘油单油酸酯液晶体系:特性、溶胀和释放动力学。
J Pharm Sci. 2009 Nov;98(11):4191-204. doi: 10.1002/jps.21724.
8
Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration.纳米结构液晶颗粒为口服后水溶性差的药物提供了长时间的持续释放效果。
J Control Release. 2011 Jul 30;153(2):180-6. doi: 10.1016/j.jconrel.2011.03.033. Epub 2011 Apr 8.
9
A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats.一种基于脂质的液晶基质,可为大鼠体内一种典型的难溶性药物提供缓释并提高其口服生物利用度。
Int J Pharm. 2007 Aug 1;340(1-2):52-60. doi: 10.1016/j.ijpharm.2007.03.020. Epub 2007 Mar 24.
10
Examining the gastrointestinal transit of lipid-based liquid crystalline systems using whole-animal imaging.采用整体动物成像技术研究基于脂质的液晶体系的胃肠道转运。
Drug Deliv Transl Res. 2015 Dec;5(6):566-74. doi: 10.1007/s13346-015-0253-z.

引用本文的文献

1
Oral Drug Delivery via Intestinal Lymphatic Transport Utilizing Lipid-Based Lyotropic Liquid Crystals.利用基于脂质的溶致液晶通过肠道淋巴转运进行口服给药。
Liquids (Basel). 2023 Dec;3(4):456-468. doi: 10.3390/liquids3040029. Epub 2023 Nov 20.
2
Lipid Nanocarriers-Enabled Delivery of Antibiotics and Antimicrobial Adjuvants to Overcome Bacterial Biofilms.脂质纳米载体介导抗生素和抗菌佐剂递送以克服细菌生物膜
Pharmaceutics. 2024 Mar 14;16(3):396. doi: 10.3390/pharmaceutics16030396.
3
Cubosomes: An Emerging and Promising Drug Delivery System for Enhancing Cancer Therapy.
立方体贴剂:一种新兴且有前途的药物传递系统,可增强癌症治疗效果。
Curr Pharm Biotechnol. 2024;25(6):757-771. doi: 10.2174/0113892010257937231025065352.
4
Technological Advances in a Therapy of Primary Open-Angle Glaucoma: Insights into Current Nanotechnologies.原发性开角型青光眼治疗中的技术进展:对当前纳米技术的见解
J Clin Med. 2023 Sep 6;12(18):5798. doi: 10.3390/jcm12185798.
5
Recent Progression in Nanocarrier based Techniques to Address Fungal Infections and Patent Status in Drug Development Process.基于纳米载体技术治疗真菌感染的最新进展及药物研发过程中的专利状况
Recent Pat Nanotechnol. 2025;19(2):183-204. doi: 10.2174/1872210517666230727090314.
6
Cubosomes in Drug Delivery-A Comprehensive Review on Its Structural Components, Preparation Techniques and Therapeutic Applications.药物递送中的立方液晶纳米粒——关于其结构成分、制备技术及治疗应用的全面综述
Biomedicines. 2023 Apr 7;11(4):1114. doi: 10.3390/biomedicines11041114.
7
Interplay of Hydropathy and Heterogeneous Diffusion in the Molecular Transport within Lamellar Lipid Mesophases.层状脂质中间相内分子传输中亲水性与非均匀扩散的相互作用
Pharmaceutics. 2023 Feb 8;15(2):573. doi: 10.3390/pharmaceutics15020573.
8
Chitosan/Lactic Acid Systems: Liquid Crystalline Behavior, Rheological Properties, and Riboflavin Release In Vitro.壳聚糖/乳酸体系:液晶行为、流变性能和核黄素体外释放。
Int J Mol Sci. 2022 Oct 30;23(21):13207. doi: 10.3390/ijms232113207.
9
Novel pH-Responsive Cubosome and Hexosome Lipid Nanocarriers of SN-38 Are Prospective for Cancer Therapy.新型pH响应性的SN-38立方液晶纳米粒和六角液晶纳米粒脂质纳米载体在癌症治疗方面具有前景。
Pharmaceutics. 2022 Oct 12;14(10):2175. doi: 10.3390/pharmaceutics14102175.
10
A Lipid-Based In Situ-Forming Hexagonal Phase for Prolonged Retention and Drug Release in the Breast Tissue.一种用于延长在乳腺组织中保留时间和药物释放的基于脂质的原位形成六方相。
AAPS PharmSciTech. 2022 Sep 19;23(7):260. doi: 10.1208/s12249-022-02411-9.